Corridoni Daniele, Arseneau Kristen O, Cominelli Fabio
Department of Medicine; Case Western Reserve University; Cleveland, OH USA; Digestive Health Research Center; Case Western Reserve University; Cleveland, OH USA.
Gut Microbes. 2014 May-Jun;5(3):340-4. doi: 10.4161/gmic.28404. Epub 2014 Mar 5.
Increasing evidence suggests that a deficit in innate immunity may play a causative role in the pathogenesis of inflammatory bowel disease. The most compelling support for this hypothesis comes from the genetic association of Crohn disease (CD) with carriage of polymorphisms within the NOD2 gene, which represent the most frequent genetic defect in CD. Our findings suggest that SAMP1/YitFc mice, which develop CD-like ileitis in the absence of NOD2 genetic mutations, fail to respond to MDP administration by displaying decreased innate cytokine production and impaired bacterial clearance before the onset of disease. This provides evidence that dysregulated NOD2 signaling, genetic or functional in nature, predisposes to chronic intestinal inflammation, and supports a new paradigm that CD may occur from a deficit in innate immunity as opposed to an overly aggressive immune response. This new paradigm could lead to potential development of new preventative or therapeutic modalities for patients with CD.
越来越多的证据表明,先天免疫缺陷可能在炎症性肠病的发病机制中起致病作用。这一假说最有力的支持来自克罗恩病(CD)与NOD2基因内多态性携带的遗传关联,这是CD中最常见的遗传缺陷。我们的研究结果表明,在没有NOD2基因突变的情况下发生类似CD的回肠炎的SAMP1/YitFc小鼠,在疾病发作前对MDP给药无反应,表现为先天细胞因子产生减少和细菌清除受损。这提供了证据表明,无论在基因上还是功能上,NOD2信号失调都易导致慢性肠道炎症,并支持一种新的范式,即CD可能源于先天免疫缺陷而非过度活跃的免疫反应。这一新范式可能会为CD患者带来新的预防或治疗方式的潜在发展。